Massachusetts 192nd Legislature (2021-2022) Status: In Committee 8 D cosponsors

H 1137 — An Act relative to cancer patient access to biomarker testing to provide appropriate therapy

Last action — Accompanied a study order, see H5222

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced March 29, 2021. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Stalled 26% · moderate confidence

  • In Committee

    Current position in the legislative process.

  • 8 sponsors

    1 primary, 7 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (8 D).

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

By Ms. Kilcoyne of Northborough, a petition (accompanied by bill, House, No. 1137) of Meghan Kilcoyne and others relative to insurance coverage for biomarker testing for certain cancer patients. Financial Services.

Bill Text

We don't have the full text on file for this bill yet.

Read H 1137 on the official Massachusetts source →

Action History

  1. Accompanied a study order, see H5222

  2. Senate concurred

  3. Reporting date extended to Wednesday June 1, 2022, pending concurrence

  4. Reported favorably by committee and referred to the committee on Health Care Financing

  5. Hearing scheduled for 11/09/2021 from 11:00 AM-04:00 PM in Virtual Hearing

  6. Senate concurred

  7. Referred to the committee on Financial Services

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 7 co-sponsors · 196 not signed on

Sponsors (1)

Co-sponsors (7)

Not signed on (196)

196 members have not signed on to this bill.

Show all 196 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does H 1137 do?
By Ms. Kilcoyne of Northborough, a petition (accompanied by bill, House, No. 1137) of Meghan Kilcoyne and others relative to insurance coverage for biomarker testing for certain cancer patients. Financial Services.
Who sponsors H 1137?
H 1137 is sponsored by Meghan K. Kilcoyne (Democrat), David Allen Robertson (Democrat), Christopher Hendricks (Democrat), Jessica Ann Giannino (Democrat), Carmine Lawrence Gentile (Democrat), Natalie M. Higgins (Democrat), Patricia A. Duffy (Democrat), and James K. Hawkins (Democrat).
What is the current status of H 1137?
This bill is in committee in the House. Introduced March 29, 2021. It must pass committee before a floor vote.
Where can I track H 1137?
Track H 1137 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on H 1137

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of H 1137

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →